SeerPharma Blog listing page


Recent Posts

SeerPharma to Sponsor BioSymposium on Precision Healthcare

August 22, 2023

Precision healthcare can offer and plan specific patient care, based on the genes, proteins, and other substances in a person’s body. Regarding cancer and rare diseases, precision healthcare most often means looking at how changes in certain genes or proteins in a person’s cells might affect their care and treatment options. Recent advances in...

Read More

The Impact of Annex 16 Adoption by PIC/S in Australia

August 07, 2023

The Therapeutic Goods Administration (TGA) is part of the Australian Federal Government’s Department of Health and regulates the supply, import, export, manufacturing, and advertising of therapeutic goods, including medicines in Australia.

Read More

2023 Medical Device Manufacturing Trends

August 02, 2023

Digital Transformation, Data Optimization, and Tech-Savvy Talent

Read More

Welcoming the 2023 Spring Cohort of GMP Students at UTS

July 24, 2023

SeerPharma is thrilled to welcome the 2023 Spring cohort of students studying Good Manufacturing Practice (GMP) at the University of Technology Sydney (UTS). This unique program is designed and delivered by SeerPharma in partnership with UTS. We’re thrilled to see close to 100 students now undergoing Postgraduate training in GMP with us at UTS....

Read More

2023 Trends - What is the Future of the Pharma Manufacturing Industry?

July 20, 2023

If we could predict the future of the pharma manufacturing industry, we wouldn’t have been rattled by supply disruptions throughout the pandemic. And we would’ve been able to anticipate which products would unexpectedly experience weak demand. At the very least, we could’ve predicted which winning therapies to invest in! So why do we waste time...

Read More

SeerPharma Engaged for European QP Audits in the APAC Region

July 12, 2023

SeerPharma has been engaged by multiple companies to conduct GMP audits in the Asia-Pacific region on behalf of Qualified Persons (QP) in Europe.

Read More

CSA/CSV & 21 CFR Part 11 Training for Global Diagnostics Manufacturer

July 03, 2023

The Singaporean division of a global diagnostics equipment manufacturer engaged SeerPharma to deliver training on Computer Software Assurance/Validation and 21 CFR Part 11. Multiple workshops were delivered to over 50 staff, to help them appreciate the regulatory expectations of the US FDA , for the work performed on-site.

Read More

TGA GMP Inspection Assistance for Indian and Indonesian Firms

June 29, 2023

A leading sterile pharmaceutical manufacturer in India engaged SeerPharma to assist in responding to a recent TGA GMP audit. As part of its response to the TGA, the company requested SeerPharma to visit their site in Madhya Pradesh. SeerPharma was tasked to assess the clients’ sterile facilities, documentation, quality management system, risk...

Read More

SeerPharma & Melbourne Uni Assess Impact of AI/LLMs on Quality and GMP

April 21, 2023

Publicly debuted Large Language Models (LLMs), such as ChatGPT by OpenAI (Microsoft), have initiated serious rethinking of business processes across all sectors of the economy. Consultancy firms are not immune from the potential disruption caused by these novel artificial intelligence (AI) tools. Global consulting firm PwC has recently instructed...

Read More

SeerPharma to Exhibit at ARCS 2023 June 6-8th

April 17, 2023

The Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry (ARCS) is an eminent organisation that focuses on the professional development of individuals involved in the therapeutic goods industry. To further its mission, ARCS hold an annual conference, which will be run from the 6th-8th of June at the...

Read More